Monday November 23 2009 | Biotechnology feed | All feeds

Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine

Monday 10th of November 2008 13:17

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to ... Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once- Daily Clozapine DUBLIN, November 10 /PRNewswire/ -- Azur Pharma Limited (Azur)
...
http://www.reuters.com/article/pressRelease/idUS210039+10-No...
reviewjournal.com -- PRESS RELEASES Daily news section of the Las Vegas Review-Journal. ... Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=LVRJBIO.st...
The information below is distributed by PR Newswire on behalf of ... ... Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine ... it has entered into an agreement to develop and commercialise once-daily ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=SPIHEA.sto...

Browse other news from this organisation: Azur Pharma Limited

(If any, Generated Automatically)

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.